All Stories

  1. Detecting biomarkers associated with antipsychotic-induced extrapyramidal syndromes by using machine learning techniques
  2. Feasibility Pilot Study of an Opioid Helpline for Individuals at High Risk for Opioid Use Disorder
  3. Development and implementation of a contemplative-based intervention for systemic lupus erythematosus
  4. Factors Moderating the Impact of After Death Communications on Beliefs and Spirituality
  5. Can Neutrophil-lymphocyte Ratio Be a Useful Criterion for Neuroleptic Malignant Syndrome in the Absence of Leukocytosis?
  6. Neutrophil-lymphocyte ratio (NLR): a marker beyond inflammation? Comment on PMID: 32174125
  7. Platelet mass index as an indicator of platelet activation in manic episode
  8. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder
  9. Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome
  10. Serum osmolarity and blood viscosity as a potential explanation for the pathophysiology of neuroleptic malignant syndrome
  11. Comparison of the complete blood count-derived inflammatory markers in bipolar patients with manic and mixed episodes
  12. A new interpretation of neutrophil-lymphocyte ratio from psychiatric aspect
  13. Does Blood Flow Change according to Mood? Blood Rheology in Bipolar Disorder
  14. Decreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury?
  15. Serum osmolarity in male patients with bipolar disorder manic episode
  16. Electroconvulsive Therapy and Oxidative Stress: Comment on the Article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40-46)
  17. Neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer's disease
  18. Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment
  19. Comment on "Diabetes mellitus and first episode mania associated with cardiovascular diseases in patients with older-age bipolar disorder"
  20. Differential effects of clozapine and risperidone on facial emotion recognition ability in patients with treatment-resistant schizophrenia
  21. Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters
  22. BIPOLAR DISORDER AND INFLAMMATION
  23. Peripheral Biomarkers in Bipolar Disorder Manic Episode
  24. Atherogenic Index of Plasma as a cardiovascular risk marker in manic, depressive and euthymic stages of Bipolar Disorder
  25. Paliperidone and paliperidone-palmitat induced leukocytoclastic vasculitis
  26. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
  27. Etiology of cardiovascular disease in patients with schizophrenia: current perspectives
  28. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder
  29. Illness perception of dropout patients followed up at bipolar outpatient clinic, Turkey
  30. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls
  31. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment
  32. Initial and post-treatment total oxidant–antioxidant status and oxidative stress index in male patients with manic episode
  33. The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment
  34. A Case Report of Priapism Caused by Ziprasidon
  35. Psychosis in a Female Patient With Tuberous Sclerosis
  36. The prevalence of metabolic syndrome parameters among bipolar disorder outpatients on lithium monotherapy
  37. The review of hematologic and other biochemical parameters in lithium monotherapy patients